Julie D. White
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Julie D. White has a total of 228 co-authors. Here are the top co-authors by number of shared publications:
- Peter Claes
Department of Human Genetics, KU Leuven, Leuven, Belgium
12 shared publications - Mark David Shriver
Department of Anthropology, Pennsylvania State University, University Park, Pennsylvania, USA
11 shared publications - Eric Otto Johnson
RTI International, Research Triangle Park, NC, USA
6 shared publications - Seth M. Weinberg
Center for Craniofacial and Dental Genetics, Department of Oral and Craniofacial Sciences University of Pittsburgh Pittsburgh Pennsylvania USA
6 shared publications - Jiarui Li
CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China
5 shared publications - Ryan Joseph Eller
Affiliation Department of Biology, Indiana University Purdue University Indianapolis, Indianapolis, Indiana, United States of America
5 shared publications
Latest Publications
- Open Access
- 29 August 2026
- Published by Springer Nature in Translational Psychiatry
A systematic review of substance use disorder methylome-wide association studies in postmortem human brain
- 29 August 2026
- Published by Springer Nature in Translational Psychiatry
Open AccessA systematic review of substance use disorder methylome-wide association studies in postmortem human brain
- Open Access
- 29 June 2026
- Published by Springer Nature in Nature Mental Health
A large-scale meta-analysis of DNA methylation signatures of alcohol use disorder in the Psychiatric Genomics Consortium
Despite extensive research on DNA methylation signatures associated with alcohol use disorder (AUD), findings are often inconsistent. Here we conducted a large-scale meta-analysis of epigenome-wide association studies (EWASs) to identify reliable, reproducible epigenetic markers of AUD. Seven cohorts, comprising 3,775 individuals (1,325 with AUD), contributed to this meta-analysis. Downstream analyses included differentially methylated regions, overrepresentation analyses and the construction of a methylation risk score. We identified 118 significant CpG sites associated with AUD, with the strongest association found at cg24889777 ( P = 5.12 × 10 −17 ). CpG sites were enriched for pathways related to GTPase signaling, transmembrane transporter activity and EWAS signals of alcohol consumption. The methylation risk score explained 2.06% of the variance in alcohol consumption and predicted heavy drinking in an independent cohort ( N = 2,534, area under the curve = 0.657). This analysis offers key insights into the epigenetic mechanisms of AUD and lays the groundwork for future research on methylation risk scores for the diagnosis, prognosis and treatment of AUD.
- 29 June 2026
- Published by Springer Nature in Nature Mental Health
Open AccessA large-scale meta-analysis of DNA methylation signatures of alcohol use disorder in the Psychiatric Genomics Consortium
Despite extensive research on DNA methylation signatures associated with alcohol use disorder (AUD), findings are often inconsistent. Here we conducted a large-scale meta-analysis of epigenome-wide association studies (EWASs) to identify reliable, reproducible epigenetic markers of AUD. Seven cohorts, comprising 3,775 individuals (1,325 with AUD), contributed to this meta-analysis. Downstream analyses included differentially methylated regions, overrepresentation analyses and the construction of a methylation risk score. We identified 118 significant CpG sites associated with AUD, with the strongest association found at cg24889777 ( P = 5.12 × 10 −17 ). CpG sites were enriched for pathways related to GTPase signaling, transmembrane transporter activity and EWAS signals of alcohol consumption. The methylation risk score explained 2.06% of the variance in alcohol consumption and predicted heavy drinking in an independent cohort ( N = 2,534, area under the curve = 0.657). This analysis offers key insights into the epigenetic mechanisms of AUD and lays the groundwork for future research on methylation risk scores for the diagnosis, prognosis and treatment of AUD.
- Open Access
- 1 April 2026
- Published by Oxford University Press (OUP) in AJE Advances: Research in Epidemiology
- Vol. 2 (3)
In harmony? A scoping review of methods to combine multiple 16S amplicon datasets
Robust evidence on relationships between the human microbiome and health is critical for understanding and improving the human condition. However, there is little information about methodological approaches to combine and analyze multiple microbiome (16S amplicon) datasets. To address this gap, we conducted a scoping review of studies that combined 16S sequencing data from multiple sources to understand the objectives, data sources and selection, bioinformatics, and analyses. References were identified through a systematic search of literature published between January 2011 and April 2026. Our final review included 136 articles. Despite the widespread use of the word “meta-analysis,” we found that only two-thirds of studies used a systematic process to select their dataset and 20% applied a statistical meta-analysis. Most studies (79%) combined datasets from multiple disjoint hypervariable regions. The number of hypervariable regions combined was not associated with the bioinformatic methods, but bioinformatics and the number of hypervariable regions influenced analytical resolution. Our results suggest that the microbiome community needs to examine the terminology and analytic approaches for combining datasets; that additional work is needed to explore the impact of data source on bias in combined studies; and that evaluation of methods used for feature table construction across disjoint regions is needed.
- 1 April 2026
- Published by Oxford University Press (OUP) in AJE Advances: Research in Epidemiology
- Vol. 2 (3)
Open AccessIn harmony? A scoping review of methods to combine multiple 16S amplicon datasets
Robust evidence on relationships between the human microbiome and health is critical for understanding and improving the human condition. However, there is little information about methodological approaches to combine and analyze multiple microbiome (16S amplicon) datasets. To address this gap, we conducted a scoping review of studies that combined 16S sequencing data from multiple sources to understand the objectives, data sources and selection, bioinformatics, and analyses. References were identified through a systematic search of literature published between January 2011 and April 2026. Our final review included 136 articles. Despite the widespread use of the word “meta-analysis,” we found that only two-thirds of studies used a systematic process to select their dataset and 20% applied a statistical meta-analysis. Most studies (79%) combined datasets from multiple disjoint hypervariable regions. The number of hypervariable regions combined was not associated with the bioinformatic methods, but bioinformatics and the number of hypervariable regions influenced analytical resolution. Our results suggest that the microbiome community needs to examine the terminology and analytic approaches for combining datasets; that additional work is needed to explore the impact of data source on bias in combined studies; and that evaluation of methods used for feature table construction across disjoint regions is needed.
- Open Access
- 16 February 2026
- Published by Oxford University Press (OUP) in Environmental Epigenetics
- Vol. 12 (1)
A methodology to identify a DNA methylation-based signature of prenatal air pollution exposure in the ECHO Cohort
Prenatal exposure to ambient air pollutants has been associated with adverse child health across different populations. In the absence of direct air pollution exposure measures, epigenetic biomarkers can serve as indicators of cumulative exposure. Previously, we developed a methodological pipeline to build a prediction model to distinguish infants highly exposed to air pollutants in utero based on DNA methylation in cord blood samples. Here, we test and refine this pipeline using data from multiple pregnancy cohort sites included in the Environmental influences on Child Health Outcomes (ECHO) Cohort. Levels of prenatal exposure to fine particulate matter (PM2.5), nitrogen dioxide (NO2), and 8-hour maximum ozone (O3) were modeled using geocoded address data and machine learning. DNA methylation was measured using 450K or EPIC arrays. Training and validation sets were created and matched based on exposure level, cohort site, and array type to test the performance of the pipeline prediction model using area under the curve metrics. Among the three exposures, epigenetic-based predictions of PM2.5 and NO2 produced higher area under the curve values (0.64–0.68 and 0.62–0.95, respectively) than those for O3 (0.50–0.75). We identified differences in the performance of the pipeline model across geographical regions, exposure windows, and thresholds used to distinguish “high” and “low” air pollutant exposure. Overall, this pipeline enabled the estimation of air pollution from DNA methylation data, though careful consideration of model inputs is required. Further studies will test the performance of the CpG sites identified by the pipeline to predict child health outcomes.
- 16 February 2026
- Published by Oxford University Press (OUP) in Environmental Epigenetics
- Vol. 12 (1)
Open AccessA methodology to identify a DNA methylation-based signature of prenatal air pollution exposure in the ECHO Cohort
Prenatal exposure to ambient air pollutants has been associated with adverse child health across different populations. In the absence of direct air pollution exposure measures, epigenetic biomarkers can serve as indicators of cumulative exposure. Previously, we developed a methodological pipeline to build a prediction model to distinguish infants highly exposed to air pollutants in utero based on DNA methylation in cord blood samples. Here, we test and refine this pipeline using data from multiple pregnancy cohort sites included in the Environmental influences on Child Health Outcomes (ECHO) Cohort. Levels of prenatal exposure to fine particulate matter (PM2.5), nitrogen dioxide (NO2), and 8-hour maximum ozone (O3) were modeled using geocoded address data and machine learning. DNA methylation was measured using 450K or EPIC arrays. Training and validation sets were created and matched based on exposure level, cohort site, and array type to test the performance of the pipeline prediction model using area under the curve metrics. Among the three exposures, epigenetic-based predictions of PM2.5 and NO2 produced higher area under the curve values (0.64–0.68 and 0.62–0.95, respectively) than those for O3 (0.50–0.75). We identified differences in the performance of the pipeline model across geographical regions, exposure windows, and thresholds used to distinguish “high” and “low” air pollutant exposure. Overall, this pipeline enabled the estimation of air pollution from DNA methylation data, though careful consideration of model inputs is required. Further studies will test the performance of the CpG sites identified by the pipeline to predict child health outcomes.
- Open Access
DNA Methylation Signatures of Alcohol Use Disorder – A large-scale Meta-Analysis in the Psychiatric Genomics Consortium
Despite extensive research on DNA methylation (DNAm) signatures associated with alcohol use disorder (AUD), findings are often inconsistent and not replicated. We conducted a large-scale meta-analysis of epigenome-wide association studies (EWAS) to identify reliable, reproducible epigenetic markers of AUD. Seven cohorts, comprising 3,775 individuals (1,325 with AUD), contributed to this meta-analysis within the framework of the Psychiatric Genomics Consortium Substance Use Disorders Epigenetics Working Group. Downstream analyses included the identification of differentially methylated regions, overrepresentation analyses, and the construction of a methylation risk score (MRS). We identified 118 significant CpG sites associated with AUD, with the strongest association found at cg24889777 ( p =5.12×10 -17 ) in the long non-coding RNA LOC100505942. CpG sites were enriched for pathways related to GTPase signaling and transmembrane transporter activity, as well as EWAS signals of alcohol consumption. The MRS explained 10.44% of variance in heavy drinking in an independent cohort (N=2,534, AUC=0.657). This large-scale meta-analysis offers key insights into the epigenetic mechanisms of AUD and lays the groundwork for future research on methylation risk scores for the diagnosis, prognosis, and treatment in AUD.
Open AccessDNA Methylation Signatures of Alcohol Use Disorder – A large-scale Meta-Analysis in the Psychiatric Genomics Consortium
Despite extensive research on DNA methylation (DNAm) signatures associated with alcohol use disorder (AUD), findings are often inconsistent and not replicated. We conducted a large-scale meta-analysis of epigenome-wide association studies (EWAS) to identify reliable, reproducible epigenetic markers of AUD. Seven cohorts, comprising 3,775 individuals (1,325 with AUD), contributed to this meta-analysis within the framework of the Psychiatric Genomics Consortium Substance Use Disorders Epigenetics Working Group. Downstream analyses included the identification of differentially methylated regions, overrepresentation analyses, and the construction of a methylation risk score (MRS). We identified 118 significant CpG sites associated with AUD, with the strongest association found at cg24889777 ( p =5.12×10 -17 ) in the long non-coding RNA LOC100505942. CpG sites were enriched for pathways related to GTPase signaling and transmembrane transporter activity, as well as EWAS signals of alcohol consumption. The MRS explained 10.44% of variance in heavy drinking in an independent cohort (N=2,534, AUC=0.657). This large-scale meta-analysis offers key insights into the epigenetic mechanisms of AUD and lays the groundwork for future research on methylation risk scores for the diagnosis, prognosis, and treatment in AUD.
- Open Access
In harmony? A scoping review of methods to combine multiple 16S amplicon data sets
Robust evidence on relationships between the human microbiome and health are critical for understanding and improving the human condition. However, there is little information about methodological approaches to combine and analyze multiple microbiome data sets. To address this gap, we conducted a scoping review of studies that combine sequencing data from multiple data sets to understand the study objectives, data sources and selection, feature -table assembly methods, and analyses. References were identified through a systematic search of literature published between 2011 and 2022. Our final review included 60 articles. Despite the wide-spread use of the word “meta-analysis,” we found that only 24 studies used a systematic process to select their data sets, suggesting multiple meanings of the term within the field. While more than two thirds of studies used at least one publicly available data source, 19 had to request data from the original authors. Most studies (60%) combined data sets from multiple disjoint hypervariable regions. The number of hypervariable regions combined was not associated with the table construction method, but feature table construction method and the number of hypervariable regions influenced analytical resolution. Our results suggest the microbiome community needs to examine the use of terminology and analytic approaches for combining data sets; that additional work is needed to explore the impact of data source on bias in combined studies; and invite an independent evaluation of the methods used for feature table construction across disjoint regions.
Open AccessIn harmony? A scoping review of methods to combine multiple 16S amplicon data sets
Robust evidence on relationships between the human microbiome and health are critical for understanding and improving the human condition. However, there is little information about methodological approaches to combine and analyze multiple microbiome data sets. To address this gap, we conducted a scoping review of studies that combine sequencing data from multiple data sets to understand the study objectives, data sources and selection, feature -table assembly methods, and analyses. References were identified through a systematic search of literature published between 2011 and 2022. Our final review included 60 articles. Despite the wide-spread use of the word “meta-analysis,” we found that only 24 studies used a systematic process to select their data sets, suggesting multiple meanings of the term within the field. While more than two thirds of studies used at least one publicly available data source, 19 had to request data from the original authors. Most studies (60%) combined data sets from multiple disjoint hypervariable regions. The number of hypervariable regions combined was not associated with the table construction method, but feature table construction method and the number of hypervariable regions influenced analytical resolution. Our results suggest the microbiome community needs to examine the use of terminology and analytic approaches for combining data sets; that additional work is needed to explore the impact of data source on bias in combined studies; and invite an independent evaluation of the methods used for feature table construction across disjoint regions.
- Open Access
- 12 October 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (4) , 1617-1626
Gene expression differences associated with alcohol use disorder in human brain
Excessive alcohol consumption is a leading cause of preventable death worldwide. To improve understanding of neurobiological mechanisms associated with alcohol use disorder (AUD) in humans, we compared gene expression data from deceased individuals with and without AUD across two addiction-relevant brain regions: the nucleus accumbens (NAc) and dorsolateral prefrontal cortex (DLPFC). Bulk RNA-seq data from NAc and DLPFC (N ≥50 with AUD, ≥46 non-AUD) were analyzed for differential gene expression using modified negative binomial regression adjusting for technical and biological covariates. The region-level results were meta-analyzed with those from an independent dataset (NNAc = 28 AUD, 29 non-AUD; NPFC = 66 AUD, 77 non-AUD). We further tested for heritability enrichment of AUD-related phenotypes, gene co-expression networks, gene ontology enrichment, and drug repurposing. We identified 176 differentially expressed genes (DEGs; 12 in both regions, 78 in NAc only, 86 in DLPFC only) for AUD in our new dataset. After meta-analyzing with published data, we identified 476 AUD DEGs (25 in both regions, 29 in NAc only, 422 in PFC only). Of these DEGs, 17 were significant when looked up in GWAS of problematic alcohol use or drinks per week. Gene co-expression analysis showed both concordant and unique gene networks across brain regions. We also identified 29 and 436 drug compounds that target DEGs from our meta-analysis in NAc and PFC, respectively. This study identified robust AUD-associated DEGs, contributing novel neurobiological insights into AUD and highlighting genes targeted by known drug compounds, generating opportunity for drug repurposing to treat AUD.
- 12 October 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (4) , 1617-1626
Open AccessGene expression differences associated with alcohol use disorder in human brain
Excessive alcohol consumption is a leading cause of preventable death worldwide. To improve understanding of neurobiological mechanisms associated with alcohol use disorder (AUD) in humans, we compared gene expression data from deceased individuals with and without AUD across two addiction-relevant brain regions: the nucleus accumbens (NAc) and dorsolateral prefrontal cortex (DLPFC). Bulk RNA-seq data from NAc and DLPFC (N ≥50 with AUD, ≥46 non-AUD) were analyzed for differential gene expression using modified negative binomial regression adjusting for technical and biological covariates. The region-level results were meta-analyzed with those from an independent dataset (NNAc = 28 AUD, 29 non-AUD; NPFC = 66 AUD, 77 non-AUD). We further tested for heritability enrichment of AUD-related phenotypes, gene co-expression networks, gene ontology enrichment, and drug repurposing. We identified 176 differentially expressed genes (DEGs; 12 in both regions, 78 in NAc only, 86 in DLPFC only) for AUD in our new dataset. After meta-analyzing with published data, we identified 476 AUD DEGs (25 in both regions, 29 in NAc only, 422 in PFC only). Of these DEGs, 17 were significant when looked up in GWAS of problematic alcohol use or drinks per week. Gene co-expression analysis showed both concordant and unique gene networks across brain regions. We also identified 29 and 436 drug compounds that target DEGs from our meta-analysis in NAc and PFC, respectively. This study identified robust AUD-associated DEGs, contributing novel neurobiological insights into AUD and highlighting genes targeted by known drug compounds, generating opportunity for drug repurposing to treat AUD.
- Open Access
Alcohol, smoking, and brain structure: common or substance specific associations
Alcohol use and smoking are common substance-use behaviors with well-established negative health effects, including decreased brain health. We examined whether alcohol use and smoking were associated with the same neuroimaging-derived brain measures. We further explored whether the effects of alcohol use and smoking on the brain were additive or interactive. We leveraged a cohort of 36,309 participants with neuroimaging data from the UK Biobank. We used linear regression to determine the association between 354 neuroimaging-derived brain measures and alcohol use defined as drinks per week, pack years of smoking, and drinks per week x pack years smoking interaction. To assess whether the brain associations with alcohol are broadly similar or different from the associations with smoking, we calculated the correlation between z-scores of association for drinks per week and pack years smoking. Results indicated overall moderate positive correlation in the associations across measures representing brain structure, magnetic susceptibility, and white matter tract microstructure, indicating greater similarity than difference in the brain measures associated with alcohol use and smoking. The only evidence of an interaction between drinks per week and pack years smoking was seen in measures representing magnetic susceptibility in subcortical structures. The effects of alcohol use and smoking on brain health appeared to be additive rather than multiplicative for all other brain measures studied. 97% (224/230) of associations with alcohol and 100% (167/167) of the associations with smoking that surpassed a p value threshold are in a direction that can be interpreted to reflect reduced brain health. Our results underscore the similarity of the adverse associations between use of these substances and neuroimaging derived brain measures.
Open AccessAlcohol, smoking, and brain structure: common or substance specific associations
Alcohol use and smoking are common substance-use behaviors with well-established negative health effects, including decreased brain health. We examined whether alcohol use and smoking were associated with the same neuroimaging-derived brain measures. We further explored whether the effects of alcohol use and smoking on the brain were additive or interactive. We leveraged a cohort of 36,309 participants with neuroimaging data from the UK Biobank. We used linear regression to determine the association between 354 neuroimaging-derived brain measures and alcohol use defined as drinks per week, pack years of smoking, and drinks per week x pack years smoking interaction. To assess whether the brain associations with alcohol are broadly similar or different from the associations with smoking, we calculated the correlation between z-scores of association for drinks per week and pack years smoking. Results indicated overall moderate positive correlation in the associations across measures representing brain structure, magnetic susceptibility, and white matter tract microstructure, indicating greater similarity than difference in the brain measures associated with alcohol use and smoking. The only evidence of an interaction between drinks per week and pack years smoking was seen in measures representing magnetic susceptibility in subcortical structures. The effects of alcohol use and smoking on brain health appeared to be additive rather than multiplicative for all other brain measures studied. 97% (224/230) of associations with alcohol and 100% (167/167) of the associations with smoking that surpassed a p value threshold are in a direction that can be interpreted to reflect reduced brain health. Our results underscore the similarity of the adverse associations between use of these substances and neuroimaging derived brain measures.
- Open Access
- 14 August 2024
- Published by Elsevier in Biological Psychiatry Global Open Science
- Vol. 4 (6) , 100375
Alcohol Use Disorder–Associated DNA Methylation in the Nucleus Accumbens and Dorsolateral Prefrontal Cortex
- 14 August 2024
- Published by Elsevier in Biological Psychiatry Global Open Science
- Vol. 4 (6) , 100375
Open AccessAlcohol Use Disorder–Associated DNA Methylation in the Nucleus Accumbens and Dorsolateral Prefrontal Cortex
- Open Access
Gene expression differences associated with alcohol use disorder in human brain
Excessive alcohol consumption is a leading cause of preventable death worldwide. Neurobiological mechanisms associated with alcohol use disorder (AUD) remain poorly understood. To further understand differential gene expression (DGE) associated with AUD, we compared deceased individuals with and without AUD across two human brain regions, nucleus accumbens (NAc) and dorsolateral prefrontal cortex (DLPFC). Bulk RNA-seq data in both NAc and DLPFC from human postmortem brains (N ≥ 50 with AUD and ≥ 46 non-AUD) were analyzed for DGE using negative binomial regression adjusting for technical and biological covariates. The region-level results were meta-analyzed with a previously published, independent dataset (N NAc = 28 AUD, 29 non-AUD; N PFC = 66 AUD, 77 non-AUD). We further utilized these data to test for heritability enrichment of AUD-related phenotypes, gene co-expression networks, gene ontology enrichment, and drug repurposing. We identified 176 differentially expressed genes (DEGs; 12 in both regions, 78 only in NAc, 86 only in DLPFC) for AUD in our new dataset. By meta-analyzing with published data, we identified 476 DEGs (25 in both regions, 29 only in NAc, 422 only in PFC). Of these DEGs, we found 17 genes that were significant when looked up in GWAS of problematic alcohol use or drinks per week. Gene co-expression analysis showed both concordant and unique gene networks across brain regions. We also identified 29 and 436 drug compounds that target DEGs from our meta-analysis in NAc and DLPFC, respectively. This study identified robust AUD-associated DEGs, providing novel neurobiological insights into AUD and highlighting genes targeted by known drug compounds, generating opportunity for drug repurposing to treat AUD.
Open AccessGene expression differences associated with alcohol use disorder in human brain
Excessive alcohol consumption is a leading cause of preventable death worldwide. Neurobiological mechanisms associated with alcohol use disorder (AUD) remain poorly understood. To further understand differential gene expression (DGE) associated with AUD, we compared deceased individuals with and without AUD across two human brain regions, nucleus accumbens (NAc) and dorsolateral prefrontal cortex (DLPFC). Bulk RNA-seq data in both NAc and DLPFC from human postmortem brains (N ≥ 50 with AUD and ≥ 46 non-AUD) were analyzed for DGE using negative binomial regression adjusting for technical and biological covariates. The region-level results were meta-analyzed with a previously published, independent dataset (N NAc = 28 AUD, 29 non-AUD; N PFC = 66 AUD, 77 non-AUD). We further utilized these data to test for heritability enrichment of AUD-related phenotypes, gene co-expression networks, gene ontology enrichment, and drug repurposing. We identified 176 differentially expressed genes (DEGs; 12 in both regions, 78 only in NAc, 86 only in DLPFC) for AUD in our new dataset. By meta-analyzing with published data, we identified 476 DEGs (25 in both regions, 29 only in NAc, 422 only in PFC). Of these DEGs, we found 17 genes that were significant when looked up in GWAS of problematic alcohol use or drinks per week. Gene co-expression analysis showed both concordant and unique gene networks across brain regions. We also identified 29 and 436 drug compounds that target DEGs from our meta-analysis in NAc and DLPFC, respectively. This study identified robust AUD-associated DEGs, providing novel neurobiological insights into AUD and highlighting genes targeted by known drug compounds, generating opportunity for drug repurposing to treat AUD.